Nestle seeks to pip Unilever to grab GSK’s consumer nutrition business as Coca-Cola opts out
Nestle, the world’s largest food and drinks company, is pitted against Anglo-Dutch consumer giant Unilever in the final round of negotiations for GlaxoSmithKline’s consumer nutrition business in India that includes…
EU cracks down on blood pressure medicine made by Mylan
European Union authorities on Monday stepped in to effectively ban sales of blood pressure medicine valsartan made by an India-based unit of Mylan NV after some batches were found to…
Lupin gets USFDA nod for myelodysplastic syndrome drug
New Delhi: Drug firm Lupin Thursday said it has received approval from the US health regulator to market Decitabine for injection, used for the treatment of myelodysplastic syndromes (MDS). The…
Centre, AAP govt not ensuring regular supply of drugs to treat HIV: plea in HC
New Delhi: The Delhi High Court has sought the Centre’s stand on a plea alleging that it and the AAP government were not following through on their assurance to the…
Aurobindo Pharma to launch oncology, respiratory products in US by 2021
NEW DELHI: Aurobindo Pharma is looking to launch first set of oncology, respiratory, complex injectables and topical products in the US in the next three years as part of plans…
E-pharmacies divided over their legal status
India’s online pharmacy startups are a divided house. Two factions in the nascent e-pharmacy segment have taken diametrically opposite view on a public interest litigation that challenges the legality of…
E-pharmacies divided over their legal status
India’s online pharmacy startups are a divided house. Two factions in the nascent e-pharmacy segment have taken diametrically opposite view on a public interest litigation that challenges the legality of…
Pharma shares bullish; Cipla rises around 3%
NEW DELHI: Pharma shares were trading higher with the Nifty Pharma index up 0.75 per cent at 9287.5 on Friday. Shares of Cipla (up 2.62 per cent), Divi’s Laboratories (up…
HC poser on resale of expired meds
New Delhi: Delhi high court on Friday sought the Centre’s stand on a PIL that claimed rampant sale of expired drugs by chemists who erase the original manufacturing and expiry…
Eli Lilly considers sale of off-patent drug assets in China
Eli Lilly and Co is considering the sale of an off-patent drugs portfolio in China, Bloomberg reported on Friday, citing sources. The assets, which include antibiotics and treatments for central…
